Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Newborns Analyzed for Irregularities Associated With Metabolic Diseases

By LabMedica International staff writers
Posted on 12 Nov 2009
A high throughput batch analyzer is intended for quantitative or qualitative measurement of neonatal screening samples on 96-well microplates. More...
The instrument is fully automated, performing every stage of an assay from retrieval of the sample plate from the stacker to measurement and reporting of results.

Called a genetic screening processor (GSP) system, it simplifies analysis of newborn blood samples by being able to run more than one test at once on very small samples. The GSP can analyze blood spot samples for irregularities associated with metabolic diseases that when detected early, can often be easily treated. The GSP utilizes specific workstation software for handling the newborn screening data.

In newborn screening programs, infants are tested for a range of genetic, metabolic, or hematologic disorders. When identified within the first few days of life, these disorders are often easily managed, but if left untreated, they could lead to serious illness or even death. The testing process begins with the collection of a few drops of blood from a heel prick.

PerkinElmer's (Waltham, MA, USA) GSP system provides multianalyte analysis capability and a two-fold capacity over prior systems, the system delivers increased efficiency and flexibility over other methods, while reducing the risk of errors associated with manual processing of samples.

The GSP analyzer eliminates the need to analyze all samples in batches, and processes them as they arrive in the laboratory. This improves response time for delivering results and eases the challenge of sample workflow management. Its multi-analyte capability enables analysis of several analytes simultaneously, preserving the small sample volume for a wider range of analysis. The GSP neonatal thyroid-stimulating hormone (TSH) assay is the first assay to receive U.S. Food and Drug Administration (FDA; Silver Spring, MD, USA) clearance for the GSP instrument. Several additional newborn screening assays are in development.

Designed to be flexible the GSP can be seamlessly integrated into a range of lab operations, enabling both multianalyte screening and having the ability to run traditional immunoassays or enzymatic-assays. Other design features include the refrigeration of onboard reagents, the integration of direct access to water and waste lines to streamline processes, and dedicated software.

Related Links:
PerkinElmer
U.S. Food and Drug Administration


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.